Switch to:

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Vincent J. AngottiN/A555,3870.88%2016-01-14
William J. Dower,PhDVP, Discovery Biology201,6290.32%2006-03-15
Dr. Ronald W. Barrett,PhDCEO, Director191,7030.3%2015-09-01
William G. HarrisSVP, Finance and CFO152,7640.24%2016-01-14
Ms. Gianna M. BoskoSVP, CLO and Secretary92,8370.15%2015-01-13
Dr. Ernest Mario,PhDDirector88,7500.14%2015-05-19
Dr. Pierre V. Tran,M.D.N/A83,3310.13%2005-06-01
Dr. David R. Savello,PhDN/A78,5060.12%2014-01-13
Dr. Paul Goddard,PhDN/A50,831less than 0.1%2005-06-07
Dr. Kenneth C. Cundy,PhDSVP, Preclinical Development43,851less than 0.1%2012-03-12

Insider Charts

Insider Transactions

Insider Position Date Buy/Sell Shares Shares Owned Following This (Direct & Indirect) Trade Price ($) Cost ($1000) Price Change
Since Trade (%)
Share Ownership Details
Flynn James E2016-01-20Buy346,4176,667,391$4.091416.82.69
6,667,391 (Through Deerfield Special Situations Fund, L.P.)
Freund John GordonDirector2015-11-11Sell909502,486$6.686.1-37.1313,899 (Direct)
488,560 (Through Fund)
27 (Beneficial Ownership)
Barrett Ronald WCEO
(Click for the stocks that their CEOs have bought)
2015-09-01Sell12,500359,942$787.5-40191,703 (Direct)
168,239 (By Trust)
Barrett Ronald WCEO2015-07-15Sell25,000372,442$7.1177.5-40.85204,203 (Direct)
168,239 (By Trust)
WIERENGA WENDALLDirector2015-05-11Buy5,00028,998$5.6328.2-25.428,998 (Direct)
RIEFLIN WILLIAM JLDirector2014-12-10Sell11,010302,845$8.4993.5-50.5321,660 (Direct)
281,117 (By Trust)
68 (Through Fund)
Barrett Ronald WCEO2014-12-08Sell7,015334,682$8.3658.6-49.76166,443 (Direct)
168,239 (By Trust)
BATES GREGORY TSVP, Regulatory Affairs & QA2014-12-08Sell14,16620,747$8.35118.3-49.720,747 (Direct)
Bosko Gianna MSVP, CLO and Secretary2014-12-05Sell60,00077,072$8.45507-50.377,072 (Direct)
BATES GREGORY TSVP, Regulatory Affairs & QA2014-09-09Sell5,61220,747$5.2629.5-20.1520,747 (Direct)
Freund John GordonDirector2014-06-03Buy12,500498,395$3.9349.16.878,899 (Direct)
27 (Beneficial Ownership)
489,469 (Through Fund)
FENTON DENNIS MDirector2014-05-27Buy3,00014,300$4.0212.14.4813,000 (Direct)
1,300 (By Trust)
FRIEDMAN CATHYDirector2014-05-27Buy2,60014,900$3.9210.27.1412,300 (Direct)
2,600 (By Trust)
WIERENGA WENDALLDirector2014-05-27Buy10,00023,998$3.9939.95.2623,998 (Direct)
MARIO ERNESTDirector2014-05-23Buy30,00083,750$3.73111.912.683,750 (Direct)
Freund John GordonDirector2014-05-23Buy15,000498,395$3.735612.68,899 (Direct)
27 (Beneficial Ownership)
489,469 (Through Fund)
Barrett Ronald WCEO2014-05-23Buy2,600342,978$3.759.812173,458 (Direct)
168,239 (By Trust)
1,281 (By Children)
BERNS PAUL LDirector2014-05-15Sell2,5005,000$3.669.214.755,000 (Direct)
BERNS PAUL LDirector2014-04-24Sell2,5002,500$4.310.8-2.332,500 (Direct)
BATES GREGORY TSVP, Regulatory Affairs & QA2013-06-14Sell7,50016,540$5.3540.1-21.516,540 (Direct)
MARIO ERNESTDirector2013-05-22Buy20,00030,000$5.49109.8-23.530,000 (Direct)
MARIO ERNESTDirector2012-08-09Buy10,00010,000$8.585-50.5910,000 (Direct)
RIEFLIN WILLIAM JLDirector2011-12-16Buy10,000281,117$3.8638.68.81
281,117 (By Trust)
RIEFLIN WILLIAM JLDirector2011-11-21Buy10,000271,117$4.4444.4-5.41
271,117 (By Trust)
Barrett Ronald WCEO2011-08-11Buy7,500232,590$6.5949.4-36.2748,851 (Direct)
183,739 (By Trust)
FENTON DENNIS MDirector2010-11-12Buy1,3001,300$7.9110.3-46.9Link
Cundy Kenneth CSVP, Preclinical Development2010-02-01Sell2,00014,861$18.5137-77.31Link
Cundy Kenneth CSVP, Preclinical Development2010-01-04Sell2,00013,793$19.1838.4-78.1Link
Cundy Kenneth CSVP, Preclinical Development2009-09-17Sell1,00013,792$24.6324.6-82.95Link
Freund John GordonDirector2009-07-10Buy135,0006,200$192565-77.89
Cundy Kenneth CSVP, Preclinical Development2009-07-01Sell1,00013,792$23.2823.3-81.96
Cundy Kenneth CSVP, Preclinical Development2009-07-01Sell1,00013,792$23.2823.3-81.96
Cundy Kenneth CSVP, Preclinical Development2009-06-11Sell1,00013,792$2222-80.91
Cundy Kenneth CSVP, Preclinical Development2009-03-25Sell54413,040$2212-80.91
Cundy Kenneth CSVP, Preclinical Development2009-02-02Sell30012,370$26.958.1-84.42
Cundy Kenneth CSVP, Preclinical Development2009-02-02Sell2,70012,670$26.7972.3-84.32
Cundy Kenneth CSVP, Preclinical Development2009-01-02Sell10010,198$27.322.7-84.63
Cundy Kenneth CSVP, Preclinical Development2009-01-02Sell2,90010,298$26.5677-84.19
Gallop Mark ASVP, Research2008-12-01Sell1,200117,053$29.9535.9-85.98
Cundy Kenneth CSVP, Preclinical Development2008-11-03Sell1,00010,198$42.0242-90
Gallop Mark ASVP, Research2008-11-03Sell300118,253$41.9512.6-89.99
Gallop Mark ASVP, Research2008-11-03Sell2,700118,553$42.05113.5-90.01
Cundy Kenneth CSVP, Preclinical Development2008-10-01Sell3,00010,198$48.74146.2-91.38
Gallop Mark ASVP, Research2008-10-01Sell200121,253$48.879.8-91.41
Gallop Mark ASVP, Research2008-10-01Sell2,800121,453$48.65136.2-91.37
Gallop Mark ASVP, Research2008-09-12Sell1,000124,253$5050-91.6
Harris William GSVP, Finance and CFO2008-09-02Sell1,50030,782$49.0573.6-91.44
Gallop Mark ASVP, Research2008-09-02Sell3,000125,253$49.09147.3-91.44
Cundy Kenneth CSVP, Preclinical Development2008-09-02Sell3,00010,198$49.07147.2-91.44
WIERENGA WENDALLDirector2008-08-19Sell4,0003,998$48.54194.2-91.35
Gallop Mark ASVP, Research2008-08-14Sell1,000128,253$5050-91.6
Cundy Kenneth CSVP, Preclinical Development2008-08-14Sell1,00010,198$4949-91.43
Cundy Kenneth CSVP, Preclinical Development2008-08-01Sell2,00010,198$45.8891.8-90.85
Harris William GSVP, Finance and CFO2008-08-01Sell1,50032,282$45.8768.8-90.84
Gallop Mark ASVP, Research2008-08-01Sell2,500129,753$45.82114.6-90.83
Gallop Mark ASVP, Research2008-08-01Sell2,500129,753$45.82114.6-90.83
Gallop Mark ASVP, Research2008-08-01Sell500129,253$46.0223-90.87
Cundy Kenneth CSVP, Preclinical Development2008-07-23Sell1,00010,198$44.5144.5-90.56
Harris William GSVP, Finance and CFO2008-07-23Sell50033,782$4522.5-90.67
Gallop Mark ASVP, Research2008-07-14Sell1,000132,253$40.1640.2-89.54
Cundy Kenneth CSVP, Preclinical Development2008-07-01Sell1,00010,198$38.138.1-88.98
Harris William GSVP, Finance and CFO2008-07-01Sell1,00034,282$38.0838.1-88.97
Gallop Mark ASVP, Research2008-07-01Sell2,000133,253$38.0976.2-88.97
BERNS PAUL LDirector2008-06-16Sell12,5000$42.02525.3-90
Harris William GSVP, Finance and CFO2008-06-02Sell1,00035,282$41.8741.9-89.97
Gallop Mark ASVP, Research2008-06-02Sell300135,253$41.9612.6-89.99
Gallop Mark ASVP, Research2008-06-02Sell2,700135,553$41.86113-89.97
Cundy Kenneth CSVP, Preclinical Development2008-06-02Sell1,00010,198$41.8741.9-89.97
Cundy Kenneth CSVP, Preclinical Development2008-05-14Sell1,0009,945$44.0444-90.46
Harris William GSVP, Finance and CFO2008-05-14Sell50036,210$45.0622.5-90.68
Freund John GordonDirector2008-05-13Buy353,3331,058,257$42.4414995.5-90.1
Savello David RSVP, Development2008-05-12Sell11,19214,540$42.84479.5-90.2
Cundy Kenneth CSVP, Preclinical Development2008-05-01Sell1,00010,945$42.6142.6-90.14
Harris William GSVP, Finance and CFO2008-05-01Sell1,00036,710$42.5942.6-90.14
Gallop Mark ASVP, Research2008-05-01Sell200138,253$42.488.5-90.11
Gallop Mark ASVP, Research2008-05-01Sell2,800138,453$42.57119.2-90.13
Cundy Kenneth CSVP, Preclinical Development2008-04-04Sell1,00011,945$44.1744.2-90.49
Cundy Kenneth CSVP, Preclinical Development2008-04-01Sell1,00012,945$42.0942.1-90.02
Gallop Mark ASVP, Research2008-04-01Sell3,000141,253$41.89125.7-89.97
Harris William GSVP, Finance and CFO2008-04-01Sell1,00037,710$42.0642.1-90.01
FRIEDMAN CATHYDirector2008-03-14Buy2,3002,300$42.7698.3-90.18
Freund John GordonDirector2008-03-14Buy7,5782,720$41.61315.3-89.91
Cundy Kenneth CSVP, Preclinical Development2008-03-03Sell30013,945$50.6415.2-91.71
Cundy Kenneth CSVP, Preclinical Development2008-03-03Sell2,70014,245$50.7136.9-91.72
Gallop Mark ASVP, Research2008-03-03Sell1,100144,253$50.7355.8-91.72
Gallop Mark ASVP, Research2008-03-03Sell2,900145,353$50.71147.1-91.72
Harris William GSVP, Finance and CFO2008-03-03Sell1,50038,710$50.7476.1-91.72
Barrett Ronald WCEO, Director2008-02-19Sell1,28170,786$54.7970.2-92.33
Barrett Ronald WCEO, Director2008-02-19Sell3,66472,067$54.27198.8-92.26
Barrett Ronald WCEO, Director2008-02-19Sell3,05575,731$54.26165.8-92.26
Cundy Kenneth CSVP, Preclinical Development2008-02-01Sell1,50016,275$61.7292.6-93.2
Cundy Kenneth CSVP, Preclinical Development2008-02-01Sell2,50017,775$61.85154.6-93.21
Harris William GSVP, Finance and CFO2008-02-01Sell1,50039,376$61.7292.6-93.2
Gallop Mark ASVP, Research2008-02-01Sell1,285148,253$61.7379.3-93.2
Gallop Mark ASVP, Research2008-02-01Sell2,715149,538$61.75167.7-93.2
Barrett Ronald WCEO, Director2008-01-16Sell1,50078,786$60.7891.2-93.09
Barrett Ronald WCEO, Director2008-01-16Sell3,20080,286$60.98195.1-93.11
Barrett Ronald WCEO, Director2008-01-16Sell3,30083,486$60.76200.5-93.09
Cundy Kenneth CSVP, Preclinical Development2008-01-02Sell1,10020,275$55.9961.6-92.5
Cundy Kenneth CSVP, Preclinical Development2008-01-02Sell2,90021,375$56.04162.5-92.51
Gallop Mark ASVP, Research2008-01-02Sell1,102152,253$55.9561.7-92.49
Gallop Mark ASVP, Research2008-01-02Sell2,898153,355$56.01162.3-92.5
Harris William GSVP, Finance and CFO2008-01-02Sell1,50040,876$56.0384-92.5
Barrett Ronald WCEO, Director2007-12-17Sell10088,786$54.765.5-92.33
Barrett Ronald WCEO, Director2007-12-17Sell4,20088,886$54.48228.8-92.29
Barrett Ronald WCEO, Director2007-12-17Sell3,70093,086$54.47201.5-92.29
WIERENGA WENDALLDirector2007-12-05Sell3,0007,998$54.76164.3-92.33
Cundy Kenneth CSVP, Preclinical Development2007-12-03Sell1,00024,275$53.8153.8-92.19
Cundy Kenneth CSVP, Preclinical Development2007-12-03Sell3,00025,275$53.02159.1-92.08
Harris William GSVP, Finance and CFO2007-12-03Sell1,50042,376$53.3280-92.12
Barrett Ronald WCEO, Director2007-11-15Sell1,400177,686$54.5776.4-92.3
Barrett Ronald WCEO, Director2007-11-15Sell3,200179,086$54.23173.5-92.26
Barrett Ronald WCEO, Director2007-11-15Sell3,400182,286$54.22184.3-92.25
Cundy Kenneth CSVP, Preclinical Development2007-11-01Sell1,00028,275$49.1149.1-91.45
Cundy Kenneth CSVP, Preclinical Development2007-11-01Sell3,00029,275$49.47148.4-91.51
Harris William GSVP, Finance and CFO2007-11-01Sell1,50043,836$49.4374.1-91.5
Gallop Mark ASVP, Research2007-11-01Sell271156,253$49.6513.5-91.54
Gallop Mark ASVP, Research2007-11-01Sell2,729156,524$49.39134.8-91.5
Barrett Ronald WCEO2007-10-15Sell1,000185,686$49.4949.5-91.51
Barrett Ronald WCEO2007-10-15Sell4,000186,686$49.83199.3-91.57
Barrett Ronald WCEO2007-10-15Sell3,400190,686$49.99170-91.6
Harris William GSVP, Finance and CFO2007-10-01Sell1,50045,336$49.374-91.48
Gallop Mark ASVP, Research2007-10-01Sell3,000159,253$49.29147.9-91.48
Cundy Kenneth CSVP, Preclinical Development2007-10-01Sell1,00032,275$49.2549.3-91.47
Cundy Kenneth CSVP, Preclinical Development2007-10-01Sell3,00033,275$49.26147.8-91.47
Cundy Kenneth CSVP, Preclinical Development2007-09-18Sell2,00036,275$4590-90.67
Barrett Ronald WCEO2007-09-17Sell3,600194,086$44.28159.4-90.51
Barrett Ronald WCEO2007-09-17Sell4,800197,686$44.3212.6-90.52
Cundy Kenneth CSVP, Preclinical Development2007-09-04Sell2,00038,275$41.8383.7-89.96
Gallop Mark ASVP, Research2007-09-04Sell3,000162,253$41.82125.5-89.96
Barrett Ronald WCEO2007-08-15Sell2,300202,486$39.2690.3-89.3
Barrett Ronald WCEO2007-08-15Sell3,000204,786$39.46118.4-89.36
Barrett Ronald WCEO2007-08-15Sell3,100207,786$39.41122.2-89.34
Gallop Mark ASVP, Research2007-08-01Sell3,000165,253$43.04129.1-90.24
Cundy Kenneth CSVP, Preclinical Development2007-08-01Sell2,00040,275$43.0286-90.24
Barrett Ronald WCEO2007-07-16Sell2,217210,886$46.01102-90.87
Barrett Ronald WCEO2007-07-16Sell3,278213,103$46.13151.2-90.9
Barrett Ronald WCEO2007-07-16Sell2,905216,381$46.04133.7-90.88
Cundy Kenneth CSVP, Preclinical Development2007-07-03Sell2,00042,275$4590-90.67
Gallop Mark ASVP, Research2007-07-02Sell3,000168,253$44.82134.5-90.63
Cundy Kenneth CSVP, Preclinical Development2007-07-02Sell2,00044,275$44.8489.7-90.63
Barrett Ronald WCEO2007-06-15Sell2,200219,286$46.21101.7-90.91
Barrett Ronald WCEO2007-06-15Sell3,300221,486$46.08152.1-90.89
Barrett Ronald WCEO2007-06-15Sell2,900224,786$46.1133.7-90.89
Cundy Kenneth CSVP, Preclinical Development2007-06-04Sell1,50046,275$4567.5-90.67
Savello David RSVP, Development2007-06-04Sell13,43113,827$44.38596.1-90.54
Cundy Kenneth CSVP, Preclinical Development2007-06-01Sell2,50047,775$45.02112.6-90.67
Gallop Mark ASVP, Research2007-06-01Sell3,000171,253$45.04135.1-90.67
Cundy Kenneth CSVP, Preclinical Development2007-05-30Sell2,00050,275$4590-90.67
Cundy Kenneth CSVP, Preclinical Development2007-05-22Sell5,00052,275$42.91214.6-90.21
WIERENGA WENDALLDirector2007-05-16Sell5,00010,998$41.15205.8-89.79
NUSSBACHER KENNETH JDirector2007-05-15Sell10,00033,332$41.64416.4-89.91
Barrett Ronald WCEO2007-05-15Sell1,700227,686$41.7671-89.94
Barrett Ronald WCEO2007-05-15Sell3,400229,386$41.85142.3-89.96
Barrett Ronald WCEO2007-05-15Sell3,300232,786$41.82138-89.96
Gallop Mark ASVP, Research2007-05-14Sell8,00012,660$40.85326.8-89.72
ROBERTS BRYAN EDirector2007-05-10Sell700$41.112.9-89.78
Cundy Kenneth CSVP, Preclinical Development2007-05-01Sell2,00051,211$41.783.4-89.93
Gallop Mark ASVP, Research2007-05-01Sell3,000176,253$41.69125.1-89.93
Cundy Kenneth CSVP, Preclinical Development2007-04-26Sell10053,211$44.244.4-90.51
Cundy Kenneth CSVP, Preclinical Development2007-04-25Sell90053,311$37.8834.1-88.91
Gallop Mark ASVP, Research2007-04-25Sell1,000179,253$38.2638.3-89.02
Barrett Ronald WCEO2007-04-25Sell2,700236,086$38.12102.9-88.98
Barrett Ronald WCEO2007-04-16Sell1,900238,786$29.7556.5-85.88
Barrett Ronald WCEO2007-04-16Sell3,800240,686$29.75113.1-85.88
Cundy Kenneth CSVP, Preclinical Development2007-04-02Sell1,00054,211$27.8127.8-84.9
Gallop Mark ASVP, Research2007-04-02Sell3,000180,253$27.883.4-84.89
Barrett Ronald WCEO2007-03-22Sell2,000245,186$2550-83.2
Barrett Ronald WCEO2007-03-22Sell700244,486$2517.5-83.2
Barrett Ronald WCEO2007-03-15Sell3,000247,186$24.6574-82.96
Harris William GSVP, Finance and CFO2007-03-14Sell6,84846,727$24.75169.5-83.03
Harris William GSVP, Finance and CFO2007-03-14Sell8,15253,575$24.71201.4-83
Gallop Mark ASVP, Research2007-03-09Sell2,00018,660$25.7951.6-83.71
Cundy Kenneth CSVP, Preclinical Development2007-03-01Sell1,00055,211$25.2325.2-83.35
Gallop Mark ASVP, Research2007-03-01Sell3,000183,253$25.2375.7-83.35
Barrett Ronald WCEO2007-02-15Sell1,400250,186$28.2739.6-85.14
Barrett Ronald WCEO2007-02-15Sell4,300251,586$28.23121.4-85.12
Gallop Mark ASVP, Research2007-02-08Sell1,000186,253$3030-86
Barrett Ronald WCEO2007-02-08Sell2,700255,886$3081-86
Gallop Mark ASVP, Research2007-02-01Sell3,000187,253$24.0372.1-82.52
Cundy Kenneth CSVP, Preclinical Development2007-02-01Sell1,00056,211$24.0424-82.53
Barrett Ronald WCEO2007-01-16Sell100258,586$24.612.5-82.93
Barrett Ronald WCEO2007-01-16Sell5,600258,686$24.85139.2-83.1
Cundy Kenneth CSVP, Preclinical Development2007-01-03Sell1,00057,211$24.324.3-82.72
Gallop Mark ASVP, Research2007-01-03Sell3,000190,253$24.3273-82.73
Cundy Kenneth CSVP, Preclinical Development2006-12-22Sell1,00058,211$25.0125-83.21
Barrett Ronald WCEO2006-12-15Sell1,400264,286$25.1835.3-83.32
Barrett Ronald WCEO2006-12-15Sell4,300265,686$25.2108.4-83.33
WIERENGA WENDALLDirector2006-12-15Sell4,0000$25.02100.1-83.21
Gallop Mark ASVP, Research2006-12-01Sell400193,253$26.1510.5-83.94
Gallop Mark ASVP, Research2006-12-01Sell2,600193,653$26.0567.7-83.88
WIERENGA WENDALLDirector2006-11-06Sell5,00019,998$23.91119.6-82.43
Barrett Ronald WCEO2006-11-01Sell3,000270,756$23.7771.3-82.33
Gallop Mark ASVP, Research2006-11-01Sell100196,253$23.782.4-82.34
Gallop Mark ASVP, Research2006-11-01Sell2,900196,353$23.7668.9-82.32
Barrett Ronald WCEO2006-10-16Sell3,000273,756$23.8871.6-82.41
Gallop Mark ASVP, Research2006-10-02Sell100199,253$20.482-79.49
Gallop Mark ASVP, Research2006-10-02Sell2,900199,353$20.6559.9-79.66
Gallop Mark ASVP, Research2006-09-01Sell90222,607$21.762-80.7Link
Gallop Mark ASVP, Research2006-09-01Sell2,910202,343$21.7463.3-80.68Link
Gallop Mark ASVP, Research2006-08-29Sell1,000225,607$20.0120-79.01Link
Gallop Mark ASVP, Research2006-08-01Sell2,000227,607$16.8733.7-75.1Link
Gallop Mark ASVP, Research2006-07-06Sell1,000228,607$2020-79Link
Gallop Mark ASVP, Research2006-07-03Sell2,000229,607$1938-77.89Link
Gallop Mark ASVP, Research2006-06-01Sell3,000251,607$22.366.9-81.17Link
Gallop Mark ASVP, Research2006-05-01Sell3,000234,253$22.5367.6-81.36Link
Gallop Mark ASVP, Research2006-04-03Sell3,000237,253$21.5464.6-80.5Link
Gallop Mark ASVP, Research2006-03-15Sell1,000240,253$20.0220-79.02Link
Gallop Mark ASVP, Research2006-03-01Sell2,000241,253$19.0638.1-77.96Link
Harris William GSVP, Finance and CFO2006-02-24Sell2,13061,459$18.7439.9-77.59Link
Harris William GSVP, Finance and CFO2006-02-24Sell19,87063,589$18.48367.2-77.27Link
Gallop Mark ASVP, Research2006-02-01Sell2,000243,253$14.7929.6-71.6Link
Gallop Mark ASVP, Research2006-01-03Sell2,000245,253$17.8435.7-76.46Link
Dower William JVP, Discovery Biology2005-11-16Buy1,540202,629$8.9313.8-52.97Link
Cundy Kenneth CSVP, Preclinical Development2005-11-16Buy1,69456,322$8.9315.1-52.97Link
Gallop Mark ASVP, Research2005-11-16Buy1,733262,986$8.9315.5-52.97Link
Barrett Ronald WCEO2005-11-16Buy2,380279,136$8.9321.3-52.97Link
RIEFLIN WILLIAM JLPresident2005-11-16Buy2,272268,937$8.9320.3-52.97Link
Freund John GordonDirector2005-09-13Buy4,2001,110,559$15.1263.5-72.22Link
Freund John GordonDirector2005-09-07Buy7,4801,106,359$13.0397.5-67.77Link
Freund John GordonDirector2005-09-06Buy1,5202,197,063$1319.8-67.69Link

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.

"Shares" change (fifth column) and "Shares Owned Following This (Direct & Indirect)" transactions (sixth column) are split adjusted. The "Share Ownership Details" (last column) displayed data is as of reported.

To find out why GuruFocus thinks data on insider trade are interesting, please read:
Also See GuruFocus Insider Trade Screener:

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK